ScholarIQanswers from OpenAlex

Associations of C-Reactive Protein with 14 Cardiovascular Diseases: An Observational and Mendelian Randomization Study

PaperCitations, authors & open-access status

Associations of C-Reactive Protein with 14 Cardiovascular Diseases: An Observational and Mendelian Randomization Study is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Associations of C-Reactive Protein with 14 Cardiovascular Diseases: An Observational and Mendelian Randomization Study have?

ScholarIQcitation count

Associations of C-Reactive Protein with 14 Cardiovascular Diseases: An Observational and Mendelian Randomization Study has 0 citations in the OpenAlex counts ScholarIQ stores.

When was Associations of C-Reactive Protein with 14 Cardiovascular Diseases: An Observational and Mendelian Randomization Study published?

ScholarIQyear

Associations of C-Reactive Protein with 14 Cardiovascular Diseases: An Observational and Mendelian Randomization Study has 2023 year in the ScholarIQ index.

What is the open-access status of Associations of C-Reactive Protein with 14 Cardiovascular Diseases: An Observational and Mendelian Randomization Study?

ScholarIQoa status

Associations of C-Reactive Protein with 14 Cardiovascular Diseases: An Observational and Mendelian Randomization Study has green oa status in the ScholarIQ index.

What is the DOI of Associations of C-Reactive Protein with 14 Cardiovascular Diseases: An Observational and Mendelian Randomization Study?

ScholarIQdoi

The DOI for Associations of C-Reactive Protein with 14 Cardiovascular Diseases: An Observational and Mendelian Randomization Study is on the source record.

What is the OpenAlex record for Associations of C-Reactive Protein with 14 Cardiovascular Diseases: An Observational and Mendelian Randomization Study?

ScholarIQopenalex

The OpenAlex for Associations of C-Reactive Protein with 14 Cardiovascular Diseases: An Observational and Mendelian Randomization Study is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial